Signs of scaling after the EIC Accelerator

France · October 2019

Staff grew from 15 in 2019 to about 60 in 2026; Series B led by AVANT BIO in January 2026

Spain · January 2020

Raised a €7M round in March 2024 and won €1.89M for its share of the EU PHOENIX trial from June 2026

France · March 2024

Launched a satellite in January 2025, released a data platform and raised capital in 2026 for a €12M GEN2 plan.

Sweden · June 2023

Raised $4.5M with the EIC Fund in 2024 and reports a $1M paid pilot in Singapore in 2025.

United Kingdom · October 2025

Average staff rose from 10 to 25 between the 2022 and 2025 accounts; a £4M package closed in 2026

Italy · October 2025

Raised €3.15M in a round led by 360 Capital in November 2025, after a 2023 pre-seed

Israel · January 2020

Average staff rose from 39 to 58 and a $39.6M Series B arrived, per the 2024 group accounts

Portugal · October 2019

Revenue of €8.94M with 46 staff in 2023; about 60 staff when Carrier bought it in 2025

Spain · March 2020

€5.4M equity round in 2023, then capital increases registered in 2024, 2025 and 2026

Austria · October 2021

CORDIS reports scale-up from a few kg to about one tonne per day; actual output and sales volumes not disclosed

Netherlands · October 2020

Staff rose from 10 to 58 between the 2021 and 2024 accounts; balance sheet grew from €0.73M to €12.1M

Netherlands · March 2020

Its lung nodule AI ran at 15 of 19 NHS lung health check pilots in 2021; RadNet bought it for $45.2M in 2022

Finland · June 2019

Revenue rose from €1.61M in 2022 to €3.54M in 2025 after a 2021 IPO; H1 2026 revenue fell 46%

Sweden · October 2024

Harvested its first trees in a production forest in May 2026 and reports an EIC equity term sheet in September 2026

France · January 2020

€120M raised in 2023; 218 staff in the 2025 CSR report, against 125 cited in 2020

France · June 2021

Company reports EUR 180M raised and 250+ staff (Oct 2026); GENCI confirms a purchase, with user access in 2027.

Austria · June 2022

Installed EuroHPC's first quantum computer in Poland in 2025 and joined Amazon Braket; revenue not published

France · May 2020

EIC Fund and PRO BTP equity from 2021, 32 staff by 2024 and a 2025 combination with Trace

Spain · October 2019

€3M round closed in 2023 with the EIC Fund; a further capital increase was registered in April 2026

Norway · April 2019

Revenue rose from NOK 7.5M in 2023 to NOK 25.0M in 2025, then a €16M equity round closed in July 2026

France · May 2026

Raised a €6M equity seed round in March 2026, four times its €1.5M round of October 2023

Switzerland · March 2020

Closed an oversubscribed pre-Series A round led by HEMEX in April 2025, after a CHF 1M seed round in 2020

France · October 2019

Revenue rose from €244k in 2020 to €567k in 2024; new equity in 2024 and two capital increases in 2026

Spain · October 2021

€13.8M Series A led by Ship2B Ventures and Clave Capital in June 2025 to reach first-in-human

United Kingdom · October 2019

Average staff rose from 26 in 2019 to 47 in 2024, after a peak of 54; cash reached £4.05M at the end of 2024

France · March 2020

Raised €5.5M in 2022 and €7.5M in October 2026; staff grew from 17 in 2022 to 25 per Vestbee

Belgium · March 2023

Profitable every year from 2022 to 2025; staff grew from 4.2 to 17.8 FTE and gross margin roughly tripled.

United Kingdom · October 2025

Average staff rose from 7 to 10 and a £4.7m pilot plant was built, per the 2025 accounts

Sweden · October 2025

Staff grew from 3 to 11 between the 2023 and 2025 accounts, and a €3.3M round closed in April 2026

Spain · October 2025

A €14.5M EIC package announced in March 2026, after a €2.8M seed round in October 2023

Switzerland · April 2019

Company says sold in 19 countries by 2026; crowdfunding raised at least €1.95M in 2025 and €836,285 in 2026

Germany · October 2024

Raised a €25.7M Series A in April 2026 to build three PHOENIX 2 vehicles, with seven missions contracted

Germany · October 2024

Raised a €4.5M pre-seed round in September 2025 led by b2venture; the company names Siemens and Vestas as clients

France · March 2024

Raised a €50M Series B with the EIC Fund, reports €340M total funding and 20 firm ERA orders.

Austria · June 2019

Share capital rose from €1.5M to €2.28M after 2022; new shareholders registered in October 2025 and April 2026

Germany · January 2023

€30M Sequoia-led round in 2025; SAP and Fresenius invested in 2026; won Klinikum Stuttgart and Braunschweig tenders.

Austria · May 2020

€30M round led by Armira Growth in 2026; over 750 clients in more than 30 countries

Netherlands · June 2023

Raised more than $250M in February 2026 and reports deployments with over 600 customers.

Belgium · May 2026

A €9M first close of its Series A in April 2025; staff rose from 5.4 to 7 FTE in the 2025 accounts

Belgium · May 2020

Staff rose from 7.7 FTE in 2020 to 20.2 in 2025 after a €5.96M round with the EIC Fund in 2022

Poland · June 2019

Parent raised share capital from PLN 8.1M in 2021 to PLN 38.1M in 2026; distribution deals signed in 2026

United Kingdom · October 2024

Raised a $10M seed round in May 2026 from World Fund, Breakthrough Energy Discovery, IP Group and others

Finland · November 2023

Revenue grew from €3.4M in 2022 to €7.7M in 2025 after a €22M Series B in 2024.

Spain · March 2025

Axon Partners and CDTI invested in March 2026; registered share capital reached €15.6M in June 2026

Belgium · June 2022

Staff rose from 7.4 to 17.9 FTE in 2022-2025 and gross margin from €1.02M to €1.75M, with profits each year

Germany · March 2025

Moved into 1,400 square metres of laboratories in 2025, with about 25 staff reported in late 2024

Israel · January 2020

Raised a $50M Series D in June 2025 and reported 1,240 BeeHomes, against 12 units built in its EU project

Israel · October 2021

Voyager DSLT launched in the US (Feb 2025) and select EU markets (Sep 2025); units and milestones undisclosed.

Italy · November 2023

Reports €24M raised in 2024, counting the €10M EIC award, and won trial approvals in the UK, Italy and Belgium.

Spain · October 2019

Raised a $15M Series B in 2021; team grew from 20 at the 2019 application to 50 in April 2026

Israel · March 2023

Over 11,000 procedures, about $14.5M revenue in 2025, 130 staff; Olympus agreed to buy it for $270M.

Estonia · May 2020

Sales rose from €1,100 in 2020 to €337,249 in 2025; staff from 3 to 9 by Q3 2026

Germany · October 2021

€18M equity and €10.3M EU funding for an Elsdorf plant; up to 10,000 t/year claimed, regional fiche lists 5,050 t/year

Germany · January 2019

ITP Aero took about 10% in 2023; share capital rose from €120,000 to €157,670 by March 2026.

Sweden · October 2024

Raised $50M in December 2025; filed what it calls Sweden's first commercial reactor park application in May 2026

Switzerland · January 2019

Raised a CHF 12M Series C led by Emerald in June 2023; company reports 500+ systems by 2026

Spain · April 2019

A Zamit Capital fund took a board seat with a capital increase in November 2024.

Spain · June 2021

Ships fitted with eSAILs rose from 3 in 2023 to 13 by September 2026

Israel · October 2019

Seed round grew from $8.4M in 2022 to $25M in 2025; a 5,000-litre commercial plant opened in 2024

Netherlands · October 2024

Opened a 100 tonne-per-year demonstration plant in June 2026 and sold a 500 tonne carbon removal pre-purchase

Greece · May 2020

€8.6M Series A in 2024 and a 150 MW module line in Patras commissioned in February 2025

Switzerland · May 2026

Raised a $5.7M seed round in November 2025, with the capital increase filed in the register

Israel · March 2023

Completed a 244-patient pivotal trial and raised a $21M Series C, including the EIC, in May 2026.

Netherlands · October 2024

Building a 100,000 tonne-per-year commercial plant with Dura Vermeer and signing partnerships in Finland and Portugal

France · March 2022

Company says over 10 ground stations under contract; €57M financing in 2025 and a factory planned for 50 stations a year

Germany · March 2024

Signed a $30.6M Frontier offtake, raised a €14.5M seed and won an €8.2M German federal grant.

France · March 2020

€42M Series B in 2023 and a 560-patient pivotal trial running at 56 listed sites in 2026

Spain · March 2020

Parent CARTO raised a $61M Series C in December 2021, with the EIC Fund taking part.

Spain · March 2024

Awarded a €20M CBE JU grant with Arkema and Evonik; says its €120M Sines plant has key approvals.

Switzerland · January 2019

Staff grew from 38 in 2020 to more than 80 in 2023; share capital raised in 2023 and 2025

Sweden · October 2019

Revenue rose from SEK 107.0M in 2021 to SEK 132.9M in 2025, and it bought Finland's Fatex in 2025

Sweden · November 2023

Won a SEK 54M grant for its first production line in 2025 and raised €6.9M with a Japanese partner in 2026.

Denmark · May 2020

€4.9M seed round in 2024; average staff rose from 7 in 2021 to 16 in the 2025 accounts

Germany · January 2020

Staff rose from 21 in 2019 to over 70 by 2025; share capital was raised again in 2024 and twice in 2026

Denmark · May 2020

Average staff rose from 1 in 2023 to 9 in 2025, and total assets from DKK 18.1M to DKK 54.4M

Denmark · January 2019

Average staff rose from 12 in 2019 to 27 in 2025, and contracted recurring revenue grew 117% in 2025

United Kingdom · January 2019

Average staff grew from 12 in 2019 to 23 in 2025; new equity came in 2023, 2025 and 2026

Netherlands · June 2023

Made its first industrial-scale delivery in December 2025 and is engineering a €100M-plus, 20,000-tonne plant.

Estonia · October 2019

Lixea Sweden staff rose from 2 to 6 in 2022-2024; it won a €21.5M Innovation Fund grant in 2025

Spain · January 2020

2025 revenue of €7M and 100 staff reported in February 2026, after 20 project hires in 2020

Luxembourg · October 2022

Company-reported certified German facility, carmaker partners and projects, €20M announced in 2026.

Italy · October 2021

€11.8M round with CDP and the EIC Fund; CRMA strategic project; plans 3,000 to 20,000 t/yr capacity

Netherlands · March 2020

€11M Series A in 2022, then strategic stakes from Sekisui (2023) and Teijin (2024) and a Tokyo unit in 2025

Spain · June 2019

Raised €100M (€70M equity, €30M debt) led by Ithaka in April 2026 after an €80M bond issue in 2024

Israel · October 2019

Raised a $12M Series A in November 2022 and added named customers such as Sun World and Wish Farms by 2026

Germany · October 2025

A €6.5M seed round in January 2026, then a 1,000-tonne demonstration plant opened in April 2026

Sweden · May 2026

A SEK 16M CogniCal order and a second Nowaste picking cell, both announced in early 2026

United Kingdom · April 2019

Staff rose from 19 in 2020 to 92 in 2025; a $18M Series B2 led by Inter IKEA was announced in 2025

Finland · October 2021

€8M Series A with the EIC Fund (2023); Kontrox LASE 16 launched 2025; EIC says 2025 trial capacity fully booked

Germany · March 2022

Two satellites launched in 2025 and a €37M Series A in 2026, which the company says brings total funding to 75 million

Denmark · June 2019

Average full-time staff rose from 19 in 2019 to 46 in 2025; InfraVia injected DKK 15M of equity in 2025

Netherlands · October 2025

Balance sheet total rose from €0.48M (2022) to €3.17M (2025) per filed accounts; new round in July 2026

Ireland · April 2019

Raised €2.8M in 2024, doubled its staff within six months and began retail sales in Ireland and the UK in 2026

Sweden · October 2024

Closed a €53M B round, won €70M of other EU funding in 2025 and reports 110 staff with C5 in manufacturing

United Kingdom · October 2025

Average staff rose from 4 to 9 between the 2022 and 2025 filed accounts

Switzerland · October 2019

Closed an $8.9M equity round led by ZEISS in July 2025, taking total funding past $32M

Germany · October 2020

Closed a €20M Series B in October 2021 led by Ranpak, with €3M from the EIC Fund

France · March 2020

Revenue doubled from €9.01M in 2020 to €18.32M in 2024 in the filed accounts

Ireland · April 2019

Series B grew from $16M in 2024 to $36M in June 2026, with BGF and the EIC as new investors.

Italy · April 2019

Revenue rose from €428,809 in 2022 to €1,367,189 in 2024; it raised $12.5M in July 2024.

Finland · June 2019

$20M Series A in 2020; Finnish entity revenue rose from €1.5M in 2020 to €7.51M in 2023

Finland · January 2023

Revenue rose from €0.16M in 2023 to €1.19M in 2025; used in 21 US states; $14M Series A in July 2026.

Israel · October 2024

Came out of stealth in October 2025 with $26M raised and reported field tests in Italy and Singapore

Belgium · November 2023

Raised a €17.5M Series A in May 2026; staff grew from 1.1 in 2022 to 7.8 in 2025.

Italy · June 2023

Raised a $53M Series D in January 2026 and holds a €119.6M ESA contract for its GEA servicing vehicle.

Switzerland · October 2019

CHF 53M round in January 2022; staff grew from over 50 in 2022 to over 150 by 2024

Spain · October 2025

US parent Dalan Animal Health closed a $3M SAFE seed round in November 2025

Switzerland · October 2019

CHF 15M round led by Taranis in April 2026, after a US DOE grant of about $6M in January 2025

Netherlands · October 2021

200 thrusters on 50+ satellites; group revenue over $15M; $25M Series B in June 2026

Italy · October 2020

Revenue rose from €0.51M in 2020 to €6.0M in 2025, with a €15M Series A in 2024

Germany · October 2025

Announced a large-series supplier nomination from an unnamed global carmaker in October 2026, with production from 2028

Netherlands · June 2023

Reported 1.84 million onboarded drivers to the EIC and raised €12.5M in 2025.

Netherlands · October 2019

€8M Series A extension in December 2025 took total capital raised to €15M

Netherlands · June 2019

€4M round from Value Creation Capital and the EIC Fund in 2023; €1.54M EIC Transition share in 2026

Spain · April 2019

Closed a €14.7M equity round in September 2026, with €7.2M from the Spanish state's SETT.

Germany · March 2024

Closed an oversubscribed Series A in 2024, opened a US office and won a 2 kW array order from Intuitive Machines.

Switzerland · October 2025

Seed round reached $23M in April 2025 and a 500-tonne showcase plant opened in July 2026

Germany · May 2026

Closed a €12M round in September 2025, per the company, about €8M of it from Companisto investors

Italy · October 2019

Revenue rose from €18.1M in 2019 to €36.4M in 2025, and staff reached 153 in the 2025 accounts

Portugal · April 2019

Raised a $7.15M Series A led by Armilar in October 2022, a year after the EIC project ended.

Norway · October 2021

60+ enterprise clients in 30+ countries; 750M hectares processed; 2024 revenue NOK 21.4M

France · March 2022

Factory opened, €30M Series A completed in 2025 and a multi-year order for several hundred thousand modules a year

Germany · May 2020

Revenue rose from €9.9M in 2022 to €11.4M in 2023; average staff from 76 to 83

Czechia · April 2019

Average staff rose from 4.67 in 2019 to 32 in the 15 months to March 2025, per the Czech filed accounts

Denmark · June 2023

Staff rose from 10 in 2023 to 23 in 2025; first 250 kW unit delivered to a customer in 2026.

Switzerland · January 2020

€14.35M Series A in June 2023, extended to €16M in January 2025, with the EIC Fund among investors

France · June 2019

Closed a €16M Series B in 2025 and bought the Albi boilermaker DIVINA in 2026

France · June 2019

Announced €10M in 2023 and €21M in 2025 (€18M equity, debt pending) to expand binder production

Austria · March 2024

Raised €10.5M led by KSB with the EIC Fund in 2025 and won Innovation Fund support for a 100-unit-a-year factory.

Switzerland · May 2026

A 2026 capital increase created seed preferred shares and converted CHF 5.25M of claims, per the register

Germany · October 2024

Raised a €57M Series A in May 2026 and reported over €54M of signed orders and more than 100 staff

France · October 2022

Revenue rose from €106k in 2021 to €2.27M in 2023, followed by a $48M Series B and US launch

France · January 2019

Series B of $30M in 2023, expanded to $35M, plus a $5M French state grant in 2025

France · April 2019

Raised €45M in July 2026; staff grew from 32 in 2021 to nearly 250 in 2026

Finland · May 2026

Staff rose from 2 to 12 and revenue from €93,000 to €323,000 between 2022 and 2025, per Asiakastieto

Israel · January 2019

Listed on Nasdaq in 2024; 2025 revenue $1.14M against $108k in 2024, mostly from buying Evoke Neuroscience

Switzerland · April 2019

CHF 23.5M Series B in December 2024; over 2,500 vehicles moved daily per a July 2026 release

Sweden · October 2024

The EIC Fund joined a SEK 45M round led by Turbine Capital in May 2026, after verification at a Stora Enso paper mill

Bulgaria · October 2024

Raised $205M in September 2026; 2025 revenue reported at €34M to €35M, up more than 55%

Germany · October 2019

Grid unit spun off in 2021 with E.ON and N-ERGIE as customers; Implisense lists 46 staff there for 2024

Italy · October 2022

Full-scale 200 MWh plant since 2025; Google partnership; projects planned in US, India, Australia.

Germany · October 2022

Over one million inspections for Shell, BP, BASF and others and a $13.5M Series A in 2025, per the company

Norway · January 2019

Paid-in equity rose from NOK 167M to NOK 354M in 2023 to 2025; storage orders grew from 5 MWh to 40 MWh by 2026

Italy · June 2021

Account summaries report revenue growth from €863,600 in 2023 to €3,719,050 in 2025, with profits in 2023–2025

Austria · April 2019

Raised €6M in 2022 and a further round in 2024; won a contract for nearly 300 US turbines in 2026.

Iceland · October 2019

Raised a €20M Series A in 2021; team grew from 9 permanent staff to 31 people by January 2024.

Sweden · April 2019

Staff rose from 20 in 2020 to 41 in 2024; SEK 69M raised in May 2024 and an own factory opened in 2023

Finland · January 2019

Revenue rose from €354,000 in the year to June 2021 to €5.96M in 2024 and €4.79M in 2025, both profitable

Austria · June 2019

Staff grew from 6 to 36 between the 2019 and 2025 accounts, after a €2.5M round in 2021

France · March 2020

Raised €8M in 2023 and €2.85M in 2025 and moved EXL01 into four oncology Phase 2 trials from 2024

Spain · October 2020

Fourth strategic round closed in September 2026; staff passed 40 by 2023 per its CORDIS report

Netherlands · March 2025

Raised a €2.5M seed round in 2024 and signed a €2.49M EIC grant in 2025; networks in at least three countries

Finland · March 2020

Raised €40.1M in an April 2026 rights issue to fund a randomised Phase 2b trial

Germany · November 2023

Raised €100M in November 2025 and hired a string of senior semiconductor executives in 2026.

Italy · March 2023

Raised an €8.64M Series A in 2025; revenue up 73% to €1.64M in 2025; 750 probes in 25+ countries.

United Kingdom · May 2026

Average staff rose from 3 to 15 between the 2023 and 2025 accounts; a £7.7M round closed in 2024

Switzerland · June 2019

CHF 13.7M Series B in 2022, a CHF 10M round in 2024 and 1,000 units deployed by April 2026

Spain · January 2020

€4.5M round in 2021 and €11.2M Series A led by Kibo Ventures in November 2023

Czechia · April 2019

Parent sales rose from CZK 0.98M in 2019 to CZK 43.3M in 2025; average staff rose from 6 to 13 in 2025.

Norway · April 2019

Staff rose from 32 in 2019 to 72 in 2026; revenue grew from NOK 89.4M (2023) to NOK 119.1M (2025)

Spain · March 2024

Closed a €4M Series A co-led by Lombard Odier and the EIC Fund and opened a 5,000 m² industrial plant in 2026.

Belgium · January 2020

€13M Series B in 2025; average staff rose from 8.7 to 15.7 FTE between the 2021 and 2025 accounts

Austria · May 2026

A €10M round reported in October 2025, and staff reported at 22 in 2025 and 27 in March 2026

Spain · June 2019

Share capital raised from €280,000 to €1.951M in 2025; 2024 sales in the €1M to €2.5M band

Ireland · May 2020

Revenue of £264,000 in the first half of 2026 against nil a year earlier, after a €5.7M investment in 2025

Germany · October 2020

Grew from a few founders to around 20 staff and three large moulding machines by 2025

Spain · October 2024

Completed a $20M Series A in January 2026 backed by NYK Line and Stolt Ventures to scale across ports

Germany · November 2023

Grew to 23 staff without outside investors and produces series of up to 12,000 parts.

Spain · April 2019

Raised a $4.6M seed round led by Hoxton Ventures in June 2023

United Kingdom · March 2020

Turnover rose from $0.89M in 2021 to $6.60M in 2024 in the group accounts

France · March 2023

€15M Series A in 2024, Airbus contracts, and a DGA framework worth up to €120M in 2026.

Netherlands · March 2025

Announced a €10M equity seed round and €6M of grants in April 2026

Italy · January 2019

Revenue rose from €13.5M in 2019 to €14.5M in 2025, with a profit in every year

Sweden · January 2020

Raised about SEK 64M in 2025 and 2026 and started a Phase III trial of Alpha1H in September 2026

Sweden · May 2020

Raised a $107M Series B in 2024 and $40M more in 2025; flew its X1 demonstrator in August 2026

France · May 2020

Sold to Allegro for $20.2M in 2022; Allegro launched Power-Thru drivers built on it in 2023 and 2024.

France · October 2024

Raised a €15M Series A with the EIC Fund in November 2025 and planned to double its workforce by 2026

Spain · March 2025

A second Series B close in June 2026 took the round above €42M, with the EIC Fund joining

Germany · June 2019

Staff grew from 20 at the 2019 EIC project start to more than 100 in 2026; over €50M equity raised in September 2026

Finland · March 2024

Raised $7.4M co-led by the EIC Fund in July 2026; revenue grew from €50k in FY2023 to €504k in FY2025.

Spain · March 2022

Company reports 50% revenue growth and doubled shipments in 2024; devices using its parts rose from 25M to 60M+

France · October 2024

Signed a multi-target Servier collaboration with a potential value above €1B in January 2026

Israel · June 2019

Raised a $24M Series B1 in October 2020 and reported 228% growth in new annual recurring revenue

France · March 2024

Raised a $40M growth round in September 2026 and reports over 250 medical centres and 120,000 patients monitored.

Spain · June 2019

Winery clients grew from over 100 in 2021 to 170 in 2024, when two funds bought 25%

Netherlands · January 2023

IVDR-certified test being implemented in European hospital labs; $16M Series A co-led by NATO Innovation Fund, 2026.

Germany · October 2020

Staff rose from 47 FTE to 132 on average by 2023; a Series B led by Piva Capital closed in January 2024

Netherlands · January 2023

Launched Pulsar commercially in May 2025 after a $21M Series A; began work with ODM Joya by December 2025.

Norway · May 2020

Revenue rose from NOK 2.4M in 2023 to NOK 6.6M in 2025, backed by new equity in 2024 and 2025

Austria · April 2019

Alder bought a majority in 2023 and Insort bought TriVision in 2025; staff went from 30 in 2018 to a 51 to 100 band

Sweden · October 2019

Net sales rose from SEK 6.3M in 2023 to SEK 14.5M in 2025 in the filed accounts

Italy · October 2025

Team grew to 19 with five hires after CASSINI, per EUSPA in 2025; first US office opened in 2026

France · November 2023

Raised a €13M Series A with the EIC Fund in December 2024 and flew its first thruster in 2025.

Spain · October 2025

Raised a €15M seed round led by Amadeus Capital Partners in September 2026

Spain · October 2024

Raised a $125M Series B in September 2026 co-led by Maverick Silicon and Light Street Capital, with Nvidia

Finland · March 2020

Revenue rose from €16.4M in 2024 to €31.3M in 2025; listed on Nasdaq in July 2026 with over 400 staff.

Germany · January 2020

€2.8M seed in 2022, a pre-Series A in 2024 and €1.05M crowdfunded in 2026; team of 10 in 2020, 17 in 2026

Finland · October 2024

Raised a Series A led by Plural in April 2025, bringing total funding to $36.5M

France · January 2020

€17M round in November 2023; Karos France reported €13.59M revenue in 2023, against €2.8M for Karos in 2020

Ireland · March 2020

Raised a €5.65M Series A in June 2021; FuturaSun put its glass into a module line in 2026

France · June 2019

Raised €40M in March 2022, taking total funding to €72M; 50 to 99 staff in the 2024 register

Germany · January 2020

First part of a Series B led by DILO closed in June 2024 with a double-digit million euro sum.

Germany · March 2020

Raised a €13M round in 2025, bringing total funding above €30M, with systems deployed worldwide.

France · June 2021

EUR 16M raised in 2024; named applications and a 2026 SmartSolve partnership; sales growth unquantified.

Iceland · October 2020

€6M Series A led by the NATO Innovation Fund in September 2026

France · October 2021

€43M Series B package (Oct 2025) incl. bank and France 2030 funding; capacity target 1,500 implants/year

Finland · October 2021

Bought by Normet (€484M 2023 sales) in 2024; Toras 35 in customer production use in 2026

Germany · June 2019

€11.5M Series A extension in 2021 and capital increases in 2024 and 2026, per the register

Netherlands · October 2024

Raised €40M in June 2026 with EIC Fund equity through STEP Scale Up, after €20M of EIB financing

Netherlands · January 2019

Closed a €43M capital raise in January 2026; anode roll production began at PlantOne in 2026

Switzerland · January 2020

More than 80 staff and 50% average yearly growth, as reported by Bits&Chips in December 2025

Germany · March 2022

About 130 staff and €25M Series B in 2024, then a €28M+ round with the EIC in 2026

Austria · May 2020

Staff grew from 20 in 2022 to 25 in 2025 after a €6M Series A in September 2022

France · November 2023

Announced ~€50M financing in 2025 incl. €24M equity, brought its first radar online, won a CNES data contract.

Denmark · October 2021

DKK 60M round with the EIC (Dec 2023); Q3 2026 samples announced; shipment unconfirmed as of 2 November

Ireland · March 2020

Raised a $22M Series A3 in December 2023 and won three FDA 510(k) clearances in 2025 and 2026

Netherlands · March 2020

Group turnover rose from €17.9M in 2022 to €23.5M in 2024; €20M EIB venture debt in 2024

Ireland · March 2023

Raised $15M in 2024 and $21M in 2026, over $50M in total, for US expansion.

Finland · October 2024

Revenue grew from €72k in 2021 to €1.3M in 2024; staff from 2 to 21 by 2025

Germany · November 2023

Raised a €3M seed round in 2025, had 34 staff and issued new shares again in April 2026.

Spain · November 2023

Raised an €8M Series A with the EIC Fund in 2025 and reports multi-million euro sales in several continents.

Switzerland · April 2019

Raised a €17.9M Series B in October 2024 and opened an Italian subsidiary for manufacturing and trials.

Belgium · October 2025

Raised €9.7M in 2025; equity rose from €3.98M to €11.05M in the 2025 accounts

Germany · April 2019

Staff rose from 25 at the 2019 EIC application to over 60 in 2026, with no outside investors, the company says

United Kingdom · May 2026

Average staff rose from 5 to 10 between the 2024 and 2025 filed accounts, after a 2024 seed round

Germany · March 2024

Extended its Series B to €113M in 2025 with the EIC Fund, EQT Ventures and Siemens Energy, for €385M total funding.

Norway · April 2019

Revenue rose from NOK 34.9M in 2020 to NOK 53.0M in 2025, and it bought Thing Technologies in 2025 or 2026

Ireland · November 2023

Picked for ESA HydRON in-orbit tests in 2026; building a 40,000 sq ft factory it says will make thousands of terminals.

Denmark · May 2026

Raised a DKK 22 million seed round led by Delphinus Venture Capital in 2026

Denmark · March 2020

Average staff rose from 5 in 2020 to 31 in 2025, funded by equity rounds in 2021, 2023 and 2025.

Sweden · March 2024

Raised a €7.3M Series A with the EIC Fund, Beiersdorf and Valio, and launched its first product in 2026.

Israel · June 2019

$93M Series E in January 2022; per the company, more than 150 sites and 100,000 patients tested by June 2025

Netherlands · June 2019

Bought by Aalberts in July 2021, then built a 1,400 m2 ISO-7 cleanroom plant in Rotterdam

Netherlands · October 2025

Seed of €1M in 2024, €350K in 2025 and an EIC grant with equity in 2026; 20 staff by March 2026

Poland · May 2026

Raised a venture round led by Balnord in September 2025; 2025 net sales rose to PLN 3.48M from PLN 1.61M

Netherlands · June 2021

EUR38M Series B2 (Oct 2023) with EIC Fund participation (share undisclosed); MUSA-3 CE mark in May 2026

Sweden · November 2023

Commissioned a 2,500 m² factory in 2025, planned foodservice entry for 2026, raised €2M in August 2026.

Sweden · May 2020

Staff rose from 4 to 14 between the 2019/20 and 2024 accounts; a $3.46M round followed in 2025

Germany · March 2020

$15.3M Series A in 2024 with the EIC Fund; Leica Biosystems and Epredia resale deals in 2026

Switzerland · October 2019

Staff grew from 2 founders in 2018 to 8 in 2022; about $2.5M revenue expected for 2023

Spain · April 2019

Staff grew from 30 in May 2023 to 65 in 2026; €8M Series A extension in June 2024

United Kingdom · March 2025

Average staff grew from 6 to 12 between the 2025 and 2026 filed accounts

Sweden · March 2020

Average staff rose from 6 in 2020 to 33 in 2025; up to €39.1M Innovation Fund grant signed in 2026

United Kingdom · October 2024

Its unit went live at enfinium's Ferrybridge plant in 2025 and a 10,000 tonne unit with IDEX was agreed in 2026

Netherlands · March 2023

Company says revenue tripled in 2025; closed a €40M+ Series B in September 2026 with the EIC Fund and Invest-NL.

Germany · May 2020

MOTEG reported almost €4M revenue for 2022, its fourth doubling in a row, and 80+ customers by Q4 2023

Netherlands · March 2023

Company says it is used by hundreds of growers in 25+ countries; raised a €2.7M seed round in September 2025.

Slovakia · October 2019

€8.12M from investors and €5.6M in Recovery Plan grants announced in March 2025

Spain · October 2021

€189M Series B in 2025; Series C of up to €500M at €1.5B pre-money in 2026; 100+ customers

France · May 2026

Reported 50-litre bioreactors and was selected for €3.7M of France 2030 funding in 2026

Belgium · June 2023

Series A in 2026, a €6M plant for 300 t a year from late 2027, and a Bayer feasibility study.

Spain · June 2019

Staff grew from 12 to 53 over Sodena's 2016 to 2025 stake; 17 towers supplied to a Fortescue wind farm by 2026

Norway · October 2025

Wage costs rose from NOK 3.5M in 2023 to NOK 7.5M in 2025 in the filed accounts

Switzerland · May 2026

Capital increases in 2025 and 2026 and €10M of EIC Fund equity announced in June 2026

Switzerland · May 2020

Series A led by CirCap with the EIC Fund in October 2023; capital increases registered in 2025 and 2026

France · October 2019

Holcim took a stake of about 20% in 2023 and share capital rose again in March 2025.

Italy · October 2024

Raised an €83.5M Series A in October 2025, including €15M of EIC Fund equity confirmed in January 2026

Germany · October 2024

Raised a €4M seed round in March 2026 to grow the team and open a Munich office

France · October 2025

Announced a €16M seed round in November 2025, after a €3.5M round in May 2024

Netherlands · March 2024

Raised $380M at a $1.6B valuation in 2026; it says QUADRA runs in a high-volume fab and won repeat orders.

France · October 2021

€24.4M Series A with the EIC Fund; €7.248M EU contribution to a randomized Phase 2b project in 2026

Spain · March 2025

Announced a $20M seed round led by Alstin Capital in June 2026; capital increases entered in July 2026

Netherlands · October 2024

Reports more than 500 treatments in four European centres and €40.1M raised, with a launch targeted for 2027

Germany · October 2020

Average staff rose from 34 to 55 between the 2021 and 2023 accounts; €30M raised in 2023

Netherlands · October 2022

150+ hospitals deployed and 30 more contracted in 12 countries; 70,000+ suspected stroke patients in 2025.

Denmark · October 2019

Raised €26M in 2021 with the EIC Fund and €29M in 2024, then was sold to Radiant Opto-Electronics in 2025

Sweden · October 2025

Revenue rose from SEK 5.7M in 2023 to SEK 34.6M in 2025 per the filed accounts summary

France · June 2019

Revenue rose from €1.89M in 2019 to €4.74M in 2023 in its filed accounts, with a profit each year.

Norway · June 2019

Equity rose from NOK 3.49M to NOK 20.56M in 2024 after a share issue; wage costs nearly tripled by 2025

Sweden · May 2026

Average staff rose from 24 in 2023 to 67 in 2025, per the filed accounts

Belgium · October 2024

Raised a €2M seed round in 2024; total assets grew from €0.61M in 2022 to €3.92M in 2025

France · October 2019

Raised a $15M Series A led by WAVE Equity Partners with the EIC in March 2022

Ireland · October 2020

Staff grew from 3 to 16 during the EIC project; a €4.6M equity round closed in January 2025

Israel · March 2024

Nurami says the EIC Fund led its Series B in June 2025; FDA-cleared ArtiFascia began preliminary US sales in 2025.

Germany · October 2019

Series A in 2025 lifted share capital from €52,727 to €215,910; fleet grew from 150 (2021) to 800+

Belgium · March 2022

€16M revenue in 2025, 200+ MWh installed for 400+ businesses and a €10M Series A in 2026, per company

Netherlands · October 2022

16 Maverick robots sold out for 2025; sales in NL, BE, DE and FR; 2027 reservations open.

Germany · November 2023

Announced a €10M seed round in April 2026 led by IQ Capital and Capnamic, with the EIC Fund participating.

Israel · October 2020

Raised a $25M Series C in October 2025 and won a €7.92M Horizon Europe consortium grant in 2026

Hungary · June 2019

Total income rose from HUF 129.9M in 2023 to HUF 200.7M in 2025, per filed accounts.

Spain · March 2025

Closed a capital increase of about €58M in March 2026, after a €25M round in January 2025

Finland · March 2024

Raised $70.8M by 2024, got an FDA GRAS no-questions letter in 2025 and signed US food partners in 2026.

Finland · June 2019

Revenue rose from €3.27M in 2021 to €6.15M in 2025; €8M growth round in September 2025

Netherlands · March 2020

€30M Series C in January 2024; staff rose from 36 in 2022 to 45 in 2024 per filed accounts

Norway · May 2020

€5M Series A in June 2025; equity rose to NOK 86.3M in the 2025 accounts

Spain · June 2019

The company reported 200% team growth and over 50% higher commercial revenue in 2024.

Portugal · October 2019

Series A of $6.5M in 2023 listed by VCBacked; two capital increases registered in February 2026

Luxembourg · October 2024

Secured €25M of EIB venture debt in February 2026 for 22 satellites and launched ERMIS-1 and ERMIS-2 in March 2026

Netherlands · March 2023

Launched OrangeQS MAX and closed a €15M seed round with EIC Fund equity in 2026; IQM and Rigetti are partners.

Germany · June 2021

€55.5M Series B in January 2026 and first US installation in July 2026

Netherlands · June 2021

€8M+ Series A in December 2024; 1,000+ kitchens in 40+ countries, per the December 2024 Series A release

Netherlands · March 2024

Raised a $43M (€38M) Series A in August 2026 and signed a 1 GWh storage agreement with Budget Thuis.

France · March 2020

€10M Series B first close and a $19.5M BARDA award in 2025, then a Phase 2b trial of 2,850 people

Norway · May 2020

Sales rose from NOK 9.4M in 2023 to NOK 19.2M in 2025, with a NOK 3.86M net profit in 2025

France · May 2020

€22M round in 2022, staff from 30 in 2019 to 50 to 99 in 2024, and a $17.2M Dallas Fort Worth contract in 2025

United Kingdom · January 2019

Raised an £8M Series A+ in 2024; average staff rose from 6 to 9 in the year to September 2025

Switzerland · October 2020

$16M seed round in January 2025; staff grew from 17 in 2022 to 26 in 2025

Germany · April 2019

Payment network grew from over 700 stations in early 2021 to over 12,000 in 18 countries by October 2025

Netherlands · March 2023

Raised a €13M Series A with the EIC Fund in April 2026; published a 210-patient prospective validation.

France · October 2020

Revenue rose from €3.5M in 2024 to €16.5M in 2025; staff grew from about 100 in 2023 to about 300 in 2026

Israel · October 2019

Raised several million dollars in November 2025 after signing a US distributor in September 2025.

Ireland · April 2019

Raised €22M in March 2025 and won FDA clearance for Millipede88 in March 2026

Spain · January 2020

Raised a €6M round led by Heran Partners in February 2026; 2022 revenue rose 70.6% to €380K.

Germany · March 2024

Added distributors in the US and Canada, Japan, South Korea, China and the UK, and raised capital twice in 2025.

Finland · January 2023

Revenue rose from €2.6M in 2023 to €7.7M in 2025, with a €3.6M operating profit and 61 staff.

Portugal · June 2023

Website lists 13th place in a Deloitte Fast 50 ranking for 2024 and SME Growth status for 2025-2026.

Ireland · June 2019

Selected in 2026 for up to €10.4M of EIC blended funding after a €2.48M EIC Transition grant in 2024

Germany · October 2025

A €5M seed first closing in April 2026, after HTGF put staff above 35 in July 2025

Sweden · March 2025

Staff rose from 21 to 31 in the 2023 to 2025 accounts; a $15.5M Series B closed in August 2026

Germany · May 2026

Carmeuse Ventures joined the seed round in December 2025; a first production unit opened in Hetlingen in early 2026

Norway · January 2019

Sales revenue rose from NOK 16.0M in 2019 to NOK 34.2M in 2025; NOK 30M round in August 2025

Germany · May 2026

Raised a €50M Series A in 2024 and was selected in 2026 for Germany's €640M quantum computing competition

Netherlands · April 2019

Holding equity rose from minus €0.73M in 2022 to €8.56M in 2025 after equity rounds in 2024 and 2025

Netherlands · January 2020

Raised a €6M Series A led by Venture Medical in July 2025, with US approval funding on top

Spain · June 2019

Raised a €4M round in 2022; repair plants grew from 4 in 2022 to 6 listed in 2026.

Italy · October 2019

Revenue rose from €8.98M in 2023 to €12.0M in 2025, per filed accounts reported by Atoka

Switzerland · January 2020

CHF 7M round led by HealthCap in June 2025; named buyers in the US, Germany and Italy from 2025

Slovakia · November 2023

FDA De Novo in 2026, selected for €40M+ IPCEI funding in 2025, reports 120,000+ heart attacks detected in 2025.

Finland · January 2020

Revenue rose from €228k in 2021 to €1.74M in 2025, and a $10M Series A closed in January 2024

Ukraine · May 2020

Revenue rose from UAH 316,800 in 2024 to UAH 8.58M in 2025, and a Ukrainian venture fund bought 10.01% in 2026

United Kingdom · June 2023

Raised £8M in 2024, shipped a four-tonne MOF order in 2025 and grew from 11 to 22 staff.

Poland · March 2025

Raised a venture round from Radix Ventures in November 2025, after the July 2025 EIC financing

Germany · March 2024

Raised a €130M Series A in 2025 and €411M in July 2026; the company says total funding exceeds €650M.

Netherlands · October 2020

$26M Series A in 2024; staff rose from more than 95 in 2024 to 150+ in 2026

Germany · March 2024

QUDORA, C12 and Yaqumo adopted Plaquette in 2025 to 2026; it was integrated with NVIDIA CUDA-Q Logical in 2026.

Denmark · October 2019

Average staff rose from 6 in 2019/20 to 28 in 2024 and 27 in 2025, per the filed accounts

Netherlands · October 2024

Camera modules with its sensors announced for evaluation from October 2026; partnership with Allied Vision in 2026

Netherlands · October 2021

Quantum Transducer launched 2026 with IBM; 100 cryo switch controllers (company, 2024); €10M EIC STEP selection (2025)

Netherlands · March 2022

Parent Pasqal listed on Nasdaq in August 2026, reporting a €70.4M backlog and over 1,000 physical qubits demonstrated

United Kingdom · March 2025

Share premium rose from £2.43M to £6.54M and cash to £2.81M in the year to April 2025, per filed accounts

Germany · June 2023

Closed €15M equity, had €76M state aid approved and installed systems in the US and Taiwan in 2026.

Netherlands · March 2022

Raised a $178M Series B in May 2026; says it serves more than 50 customers in 20 countries

Netherlands · March 2024

€15M Series A co-led by the EIC Fund; company reports 20+ Alquor systems deployed and a Japanese distributor.

France · October 2024

Raised a €115M Series A in June 2026 led by Bpifrance, STMicroelectronics and SEALSQ

Israel · March 2024

Raised a $17.5M Series A led by NXP with the EIC Fund and signed foundry work with TSMC and GlobalFoundries.

Sweden · May 2026

SEK 10M share issue with three new investors announced in July 2026, next to the EIC grant

Denmark · January 2020

Average staff doubled from 11 to 22 between the 2019/20 and 2024/25 accounts

Spain · April 2019

Company-reported projects rose from over 20,000 in 2022 to over 64,000 in 2026

Germany · October 2025

Raised €5M of venture money in a Series A1 round announced in March 2026

United Kingdom · October 2019

Turnover rose from £16.7M in 2019 to £44.7M in 2025, after peaking at £69.3M in 2023

United Kingdom · October 2021

$17M Series A; installations in 7+ countries; 43 staff by 2024; majority stake bought by CP Group in 2026

Israel · January 2019

Listed in December 2025 with a $10M IPO and raised a further $6.5M in a June 2026 private placement

Israel · March 2025

Raised a $15M Series A extension and a $3M Israel Innovation Authority grant in April 2025

United Kingdom · May 2020

Staff rose from 6 in 2020 to 24 in late 2025; Series A from Orlen VC and Beiersdorf VC in May 2025

Germany · October 2022

Company reports 7 plants in customer operation and 200+ staff; $175M Series B in 2026.

France · October 2024

Raised $28M in January 2025 and doubled its team afterwards, per the company

Germany · January 2020

Multi-million financing round in December 2022; share capital raised in 2022 and 2023.

Ireland · January 2020

Series A closed in October 2023, then new share allotments filed in 2024, 2025 and 2026

France · May 2020

Raised over €20M in 2026 from a Series B plus grants; staff rose from about 20 in 2022 to about 30 in 2025

Netherlands · November 2023

Raised a $60M Series B with EIC Fund participation in 2025; says its 150-patient US pivotal began Oct 2026.

France · October 2020

Raised $31M in 2023 and began a first 1,000 m³ STACK production batch for Bouygues in 2026

Romania · October 2021

CE-marked; 1,500 preorders via Romania's state programme in 10 days; €5M round with the EIC Fund

France · October 2021

$58M Series B (2025) with NVIDIA; LEAF Light shown 2025; Tower availability Feb 2026; evaluation kit Mar 2026

Sweden · April 2019

Won a €7.49M share of a Horizon Europe demo grant in 2025; CEO says staff doubled in Q1 2026

Austria · April 2019

Raised €20M in a round led by the Hopp Family Office in April 2021; Kaufland Pay rolled out in 2023

United Kingdom · May 2026

Average staff rose from 8 in FY2024 to 18 in the seven months to January 2026, per filed accounts

Finland · October 2024

€15M of EIC equity announced in 2025 and a strategic investment from PostScriptum in 2026

Norway · January 2020

Raised €7M in 2024, launched its first product in 2025 and grew revenue to NOK 3.52M in 2025

Slovakia · May 2020

Net turnover rose from €0.74M in 2020 to €12.78M in 2025 in the filed accounts

Spain · October 2021

€10M Series A with Seventure and the EIC Fund in 2024; CE-IVD mark under IVDR in April 2026

France · October 2021

€10M Series A (2024) incl. EIC Fund; €3.71M turnover in 2025; Spain station and Belgian unit 2025; India deal 2026

France · October 2020

Group staff grew from 130 to 200 between end 2022 and March 2025, per investor Siparex.

Sweden · March 2025

Revenue rose 50% to SEK 2.95M in 2025, per Syna, after SEK 30M from shareholders in July 2025

France · October 2021

€130M Series A closed July 2025; first Rhea1 CPUs delivered to Bull for JUPITER in September 2026

Norway · June 2019

Revenue rose from NOK 58.2M in 2024 to NOK 167.4M in 2025, with a NOK 54.8M net profit, per filed accounts

Germany · May 2020

Group revenue rose from €9.02M in 2020 to €29.23M in 2025; FTE staff grew from 127 to 304.

Denmark · January 2019

Average staff rose from 29 in 2021 to 118 in 2025; revenue from DKK 0.8M to DKK 522.6M

Netherlands · June 2023

Announced its first commercial system in 2026; SDE++-backed greenhouse projects plan 23,000 t a year with its units.

Netherlands · January 2019

Raised €35M in 2020 and €100M in 2023; over 200 staff by 2026, above the 120 planned

Portugal · October 2019

$24.7M Series A in 2022; the team grew from 100 to 150 people in 2023, per the company

Germany · June 2023

Opened an industrial line in 2025, doubled capacity to 14,000 tonnes and raised up to €20M in 2026.

Belgium · October 2025

Equity rose from €2.41M to €3.39M in 2025 despite a €0.52M loss, per the filed accounts

Portugal · April 2019

Staff grew from 10 in 2019 to about 30 by 2023; it raised €2.5M in 2022 and won state VC approval in 2026

Luxembourg · March 2025

Closed a €27.5M Series A in September 2025 and booked a SpaceX Starfall mission in September 2026

France · April 2019

Raised a €75M Series B in 2022 and started a second clinical trial, for SPVN20, in October 2025

Denmark · June 2021

Completed EUR 27.5M Series A in 2025; annual report gives average employment of 34 FTE, versus 21 in 2024

United Kingdom · October 2024

Raised a €4.2M pre-Series A in February 2026 led by SWEN Capital Partners to move from pilot to tonne-scale production

Finland · November 2023

Revenue rose 92% to €1.25M in 2025, staff grew to 21 and WEG signed a partnership in 2026.

Germany · March 2025

Staff grew from 28 employees in 2024 to more than 50 in 2025, per the EIC's company page

Spain · June 2019

Staff rose from 14 in 2019 to 22 in 2022; a €1.97M EU grant share for MultiplexAI followed in 2025

Finland · June 2019

Net sales rose from €14.4M in 2019 to €21.6M in 2025 and staff from 90 to 135

Germany · June 2021

50 MWh of storage installed by September 2026, with 100 MWh more in the pipeline

United Kingdom · October 2024

Published phase I results in eClinicalMedicine in August 2026 and launched a phase 2b trial after HRA approval

France · October 2025

Closed a €38M Series C in October 2025 and moved its drug into a phase 2 trial in June 2026

United Kingdom · June 2023

Reported €12.2M Series A in 2025; staff rose from 12 in 2023 to 29 in 2025.

Denmark · March 2023

First commercial Subracable order at end 2025; €40M new equity in April 2026; staff grew from 12 to 28 in two years.

Finland · March 2022

Revenue rose from €39,000 in 2023 to €237,000 in 2025, with a €7M Series A led by ZEISS Ventures in 2025

Belgium · June 2023

Raised a €27M Series A with the EIC Fund and a €6M extension; staff rose from 3.5 to 19.9 FTEs by 2025.

Portugal · April 2019

Swire Energy Services took a majority stake in 2021; staff nearly tripled during the 2019 to 2021 project

Netherlands · October 2021

2.7 GW of flexible assets managed across Europe; €42M Series B incl. €19M from PGGM in September 2025

France · May 2026

Raised a $30M Series A in July 2026, two years after a €4.2M seed round

France · June 2023

Raised a €12M Series A in September 2025, €30M of equity in total, and employs 26 people.

Germany · October 2022

Over 300 client companies in 40+ countries, 55 staff and a €12M Series A in 2025, per the company

Netherlands · March 2025

Series A2 reached €40.4M in June 2026, with the EIC Fund and Kurma Partners joining

Italy · June 2019

Revenue rose from €2.44M in 2019 to €4.40M in 2024, with a profit in every year, per filed accounts.

Finland · January 2019

Staff grew from 11 to 16 between 2022 and 2025, and Arteche invested in September 2024.

Sweden · October 2020

Project partner Yangi raised a €10M Series A in 2025; its first serial machine ran at a customer in 2026

France · June 2019

Biogen invested up to $15M in convertible debt in December 2021; staff reached 60 by June 2022.

France · October 2021

Company reports 500+ systems delivered, about one a day (Aug 2026), and systems on 100+ satellites (Oct 2026).

France · October 2019

Raised €8M from the EIC Fund, Karista and Wind in October 2025; share capital rose to €151,732 in 2025

Germany · March 2024

Opened a 1,500-tonne-a-year industrial plant in 2026 after an €11M seed with Honda and In-Q-Tel.

Germany · June 2021

Staff grew from 40 in 2023 to about 110 when the plant opened in May 2026

Switzerland · May 2020

New Series A2 shares registered in August 2026; staff rose from 12 in 2023 to about 15 in 2025

France · June 2019

Staff grew from 26 in June 2020 to 165 in May 2025, per the company and FrenchWeb

Germany · March 2024

Says its Spanish e-methane plant sells all output on long-term contracts; raised a €20M Series A in Oct 2026.

Germany · March 2022

Battery storage business nearly tripled in 2025, per the EIB; €24M EIB venture debt announced in 2026

Lithuania · June 2021

€6M seed round in December 2023 and CE mark in May 2026

Switzerland · May 2020

USD 9M Series A led by the Orano Venture Fund in October 2026, total funding USD 25M

Germany · November 2023

Raised a €30M Series B in 2026, employs 83 people and reports double-digit million revenue.

Italy · June 2019

Revenue rose from €648,959 in 2022 to €1,936,669 in 2024; €5M round led by CDP Venture Capital in 2026

France · June 2023

Raised $47M in 2024 with the EIC and $60M in 2026, and runs a 140-patient pivotal trial at 21 sites.

Netherlands · June 2021

Phase 3 EquilibriX-S enrolling since Aug 2026; CSL funds it and holds an option to acquire VarmX; still investigational.

Switzerland · October 2025

Series B grew to $43M in July 2023; the register shows new B+ preference shares issued in May 2026

Finland · November 2023

Revenue grew from €0.42M in 2021 to €4.19M in 2025, staff to 27, and it raised €10M in 2026.

Netherlands · April 2019

€17.2M Series A in August 2026 and machines on more than 100 hectares of UK strawberries

Netherlands · June 2019

CE mark, 13 devices contracted by 2025, $70M Series B in March 2026 and FDA De Novo authorisation in August 2026.

Germany · October 2024

Reached first-in-human use at Erasmus MC in March 2026 and EMA breakthrough device status in August 2026

Ireland · October 2019

Raised €22M in 2022 and €30M from Haemonetics in 2023, then sold for €100M upfront in 2026

Netherlands · May 2026

Raised a €32.5M Series A in February 2025, then an EIC package reported at €12.5M in June 2026

France · June 2023

Raised $46M in April 2025 with EIC Fund co-financing and announced Jotunn8 tape-out in October 2025.

France · May 2020

€11M Series A in 2024, with revenue up fivefold in 2023 and more than threefold in 2024, per InnoEnergy

Estonia · October 2021

Hosting partnerships with GoDaddy (2026), Hostinger and others; 1,000+ open-source products on its VDP

France · March 2024

Sold its QDrive memory and a photon source in 2026 and partnered with Pasqal and OVHcloud.

Sweden · October 2025

EIC selection in 2026 added a €2.5M grant and a reported €4M EIC Fund equity stake to earlier venture rounds

Netherlands · October 2025

Raised a €5M round led by LUMO Labs in July 2026, after a €750k seed round in January 2024

Italy · March 2020

Closed a €30M Series D in June 2026; staff rose from 36 planned for end-2022 to 50 in the 2024 accounts

France · November 2023

Womed Leaf won FDA approval in 2025 and sells in 14 European countries; raised over €7M in 2026.

Netherlands · October 2021

aXess CE marked April 2026; US pivotal trial past 50% enrolment; EIC Fund, EIB and other financing

France · March 2020

€20M round co-led by the EIC Fund in 2021; staff grew from 8 in 2020 to a band of 20 to 49 in 2024

Italy · June 2022

€36M Series C in 2024; 600,000 farms per the company; sixth group deal announced Sep 2026

Italy · January 2019

Revenue rose from €32,000 in 2020 to €2.63M in 2024, and the EIB lent €20M in 2023

Denmark · October 2019

Average staff rose from 9 in 2020 to 31 in 2025 and gross profit from DKK 8.2M to 17.8M

Switzerland · March 2020

Closed a $7M Series A led by WI Harper in March 2026, with the EIC taking part.

Czechia · October 2025

Average staff rose from 5 to 15 between the 2023 and 2025 filed accounts

Sweden · January 2019

Raised €3.2M in 2023 and €5.0M in 2024; staff rose from 14 to 20 between the 2021 and 2025 accounts

Spain · April 2019

€1.3M round in 2023, €3M seed round in 2025 and an Olon manufacturing deal in 2026

Spain · October 2019

Voluntary insolvency declared in June 2026; staff fell from 38 in 2023 to 15 in 2026.

Denmark · June 2022

Under bankruptcy (under konkurs) since April 2026; staff had fallen from 20 in 2023 to 12 in 2024

Sweden · June 2019

Staff only grew from 7 to 10 in 2019 to 2021; the board filed for bankruptcy in February 2023 with no new capital.

Germany · October 2022

EIC project terminated early; Actome GmbH in insolvency and liquidation since 2025.

Spain · October 2021

PreveCol on sale in Spain since 2023; register puts annual sales under €500,000

United Kingdom · June 2019

Entered administration in February 2025; all remaining staff were made redundant that month.

Austria · June 2019

Insolvency proceedings entered in the Austrian company register in March 2026.

United Kingdom · October 2022

No product on sale by September 2026; cash of £5,003 and net liabilities of £498,664 at end 2025.

Germany · October 2022

Provisional insolvency administrator three months after the EIC project; eight staff; no rescue found by Nov 2026.

Spain · October 2022

Trial for CE and FDA not run under the grant; no approval found; Empresia lists turnover below €500,000.

Spain · March 2022

11 employees and micro-enterprise revenue in 2025 with a negative result; last round €1.5M

Norway · May 2020

F3 plant frozen and about 26 full-time staff temporarily laid off in May 2026 after a NOK 870.7M loss for 2025

Sweden · October 2021

Still in technology development; $3.6M raised in 2026 to move towards first commercial partners

Netherlands · October 2021

Sources reviewed 4 Nov 2026 show no trial on ClinicalTrials.gov and no funding round announced since the 2022 award

Germany · March 2022

Filed for insolvency in September 2023; proceedings opened 1 November 2023 with most staff already gone

France · May 2020

Bought by Ginkgo for $12.0M in 2022, sold for a nominal amount in 2024 with 14 staff

Romania · June 2022

Turnover of RON 235,084 in 2025 with six staff and RON 57,581 in cash at year end

Finland · January 2019

Revenue fell 53.5% to €125,000 in the year to January 2021; the company ceased in 2024.

Germany · June 2019

Entered liquidation in February 2025; its website went offline and the domain is listed for sale.

Germany · October 2021

Provisional insolvency administrator appointed Jan 2024; proceedings opened by court order dated 28 March 2024

Denmark · June 2019

Average staff fell from 6 in 2019 and 2020 to 2 in 2025; equity fell from DKK 9.58M (2018) to 1.72M (2024)

Finland · April 2019

Revenue fell 3.2% to €1.21M in 2025 while the operating loss rose to €7.76M; equity ratio 0%

Switzerland · January 2019

Put its perovskite quantum dot patents and production assets up for sale in November 2024

Austria · June 2022

Design freeze pending animal testing at the end of the EIC project; no human trial announced

Denmark · March 2020

Average staff stayed at 4 from 2023 to 2025 while equity fell to minus DKK 651,471 in 2025

Denmark · April 2019

Danish grantee average staff fell from 15 in 2020 to 7 in 2025, when it sold its activities

Israel · March 2020

UK subsidiary struck off in 2025; 3 employees and still preclinical in its 2026 crowdfunding round

Estonia · March 2023

Annual reports: sales revenue €0 in 2025, €11,284 in 2024; 2025 net loss €242,861.

Poland · January 2019

Group turnover fell from £733,517 in 2023 to £513,467 in 2024 and net assets turned negative

Germany · May 2020

Insolvency court order in June 2025, two years after a €10M Series B; in liquidation since September 2025.

United Kingdom · October 2019

Group staff fell from 65 in 2019 to 11 in 2025, with no revenue in 2024 or 2025 and a going concern warning

Finland · June 2019

9 staff and €42,000 revenue in 2025, against 35 jobs and €17M revenue projected for 2023

Slovenia · October 2020

Total revenues fell from €4.14M to €3.05M and staff from 40.2 to 35.3 between 2023 and 2025

Germany · October 2019

Staff fell from over 160 in December 2023 to 28 at the February 2026 sale to Senstar

Germany · January 2019

Insolvency proceedings opened in April 2020; the business was sold to Lika Electronic in October 2020.

United Kingdom · October 2019

Average staff fell from 10 in the year to February 2024 to 3 in each of the next two years

France · October 2021

No product approval identified in sources checked as of 3 November 2026; judicial liquidation opened in September 2026

Austria · October 2022

Insolvency proceedings opened in August 2025, four months after the EIC project ended

Spain · October 2019

Dissolved in February 2024 after a Pamplona labour court declared it provisionally insolvent in January 2024

Finland · March 2022

No revenue in the 2024 accounts and €48,000 in 2025; staff fell from 28 in 2023 to 18 in 2024 and 2025

Israel · October 2021

Device still investigational; small first-in-human study; 10-patient Vsling III trial recruiting

France · October 2022

Entered receivership on 1 July 2025 and was liquidated in January 2026 after selling its business

France · May 2020

Payments stopped in September 2023; liquidation opened in December 2024

United Kingdom · June 2019

Average staff fell from 11 to 7 and net liabilities rose to £453,506 in the March 2026 accounts

Austria · June 2022

Insolvency proceedings opened and an insolvency administrator appointed in October 2024

Norway · October 2021

2025 revenue NOK 18.3M against a NOK 40.8M loss; 8 employees

Sweden · March 2022

Net sales of SEK 41k in 2025, a year after launch, with a SEK 37.7M net loss, per accounts listed on Allabolag

Ireland · March 2023

The EIC-funded 24-patient trial had not started by project end; estimated start is now October 2026.

Finland · March 2022

Revenue fell to €33,000 in the year to May 2025, with a €1.8M operating loss and negative equity

Sweden · January 2019

Net sales of SEK 4.2M against a SEK 18.1M loss in 2023; bankrupt in July 2024 with 14 staff

France · June 2019

Net loss of €1.57M on €0.61M revenue in 2025; annual losses of €1.05M to €1.85M from 2019 to 2025

Germany · June 2019

Put itself up for sale in July 2025 and sold its RISC-V processor business to onsemi for up to $14.5M in 2026

Sweden · October 2019

Total assets fell from SEK 30.8M to SEK 17.2M between the April 2023 and December 2024 accounts

France · March 2022

Safeguard in December 2024, receivership in December 2025 and judicial liquidation from 6 January 2026

Germany · March 2020

Insolvency proceedings opened in August 2023, 13 months after the EIC project ended.

Norway · October 2020

Net loss grew from NOK 31.4M in 2021 to NOK 80.5M in 2023; bankrupt in January 2025.

United Kingdom · October 2019

Average staff fell from 28 to 22 in FY2025 accounts; creditors' voluntary liquidation from October 2026

Switzerland · June 2019

Dissolved by its shareholders in November 2023; its cyanide patents passed to Cyanco in January 2024.

Poland · October 2021

Prototyping 85% complete at project end; no certification or customer in sources reviewed on 4 Nov 2026

Spain · January 2020

Voluntary insolvency declared in May 2026; the register lists 1 to 9 staff.

United Kingdom · May 2020

Staff fell from 22 to 6 from the 2023 to 2024 accounts; the UK company entered members' voluntary liquidation in 2025.

France · November 2023

Published revenue stayed between €1.5M and €3M from 2018 to 2023, with 10 to 19 staff.

Finland · March 2024

Revenue fell 47.5% to €149,000 in 2025 with an operating loss of €267,000, despite staff growing to 11.

France · October 2019

Receivership in September 2022 and liquidation in February 2023, with 2021 revenue of €353,102.

Bulgaria · March 2022

No turnover in the 2023 or 2024 UK accounts; no commercial cargo service found in sources reviewed on 4 November 2026

Spain · June 2019

2 employees on the register; a subsidiary was recorded as provisionally insolvent over a €4,968 debt in 2024

United Kingdom · June 2022

Turnover of £20.3M in the year to June 2025, against £20.0M in the year to March 2023

France · June 2019

Receivership opened in July 2026; net profit fell from €473k in 2023 to €127k in 2024.

France · March 2022

Revenue of €4,150 and a €2.54M net loss in 2025; equity below half of share capital

Portugal · May 2020

Filed for insolvency in March 2024, a year after its EIC project ended; the court closed the case in July 2025.

Poland · March 2022

Revenue fell from PLN 3.2M in 2023 to PLN 67k in 2025; staff from 13 to 8; equity negative at end-2025

Sweden · October 2021

Phase 2b planned for 2027; no development partner shown in sources reviewed on 4 Nov 2026

Estonia · October 2022

No sales revenue reported for 2024 or 2025; staff fell from 12 in mid-2024 to 1 in Q3 2026

Hungary · January 2019

Average staff fell from 86 in 2021 to 52 in 2023; liquidation proceedings followed in October 2024.

Germany · May 2020

A financing round failed in spring 2026; the company filed for insolvency in April 2026.

Switzerland · January 2019

Moved to a Zug domicile agency in July 2023 as three of its board members left; 3 staff in 2020.

Sweden · October 2020

Staff fell from 12 to 8 between the 2021 and 2025 accounts, with net sales near zero and a SEK 9.5M loss in 2025.

Sweden · May 2020

Bankrupt since 27 June 2025 after failing to raise funds; FY2024 net sales were SEK 67,000.

France · October 2021

No Series A located; Servier collaboration announced; judicial liquidation opened in February 2026

Norway · May 2020

Net loss widened to NOK 68.8M in 2024; Florø factory shelved in 2025; 5 staff registered in 2026

Ireland · March 2020

Average staff fell from 8 in 2022 to 2 in 2023; the company was struck off in April 2025.

Germany · June 2022

Insolvent in March 2026 with four active farm sites; operations ended in August 2026 with no buyer

Belgium · October 2019

Staff fell from 33.8 FTE in 2023 to 22.6 FTE in 2025; the company sold for €2.985M in 2024

Israel · January 2020

Tracxn counted 3 employees in August 2026; no funding round or product launch announced since 2022.

Netherlands · October 2021

EIC grant terminated in 2024; sources reviewed in Nov 2026 show no product launch, funding round or news since 2021

Finland · October 2021

No public CORDIS outcome report for the 2022-24 project; Finnish register shows bankruptcy in June 2026

Finland · April 2019

TKH gave 55 staff in 2019; Oulu accounts show 19 in 2025 and revenue down from €16.4M (2021) to €3.88M

Spain · April 2019

Voluntary insolvency declared in April 2024 and concluded with a provisional closure in May 2024

Belgium · October 2022

Declared bankrupt on 23 January 2025; the EIC terminated its project on 26 February 2025

United Kingdom · June 2019

Staff fell from 13 in 2021 to 8 in 2023; creditors' voluntary liquidation began in March 2025

Sweden · January 2019

Staff fell from 17 to 12 and total income by 41% between the 2023 and 2024 accounts

Italy · April 2019

Revenue fell from €631,832 in 2020 to €513,518 in 2023, with a €20,896 loss and 5 staff.

Netherlands · March 2023

Company cites i-THYMUS scientific challenges; RAG1-SCID trial suspended after an SAE (registry, Jul 2026).

Israel · January 2019

Ceased operating in November 2024 and was voluntarily liquidated; no funding round found

Sweden · January 2020

Bankrupt in August 2023 after 21 staff in 2022; the successor company reported 2 employees in 2025

France · May 2020

Receivership in April 2023 and liquidation in July 2023 with no takeover offer

Switzerland · October 2019

Website team page lists four people in 2026, against 17 staff reported in December 2020

Belgium · May 2020

Group net sales fell 86% to SEK 5.7M in 2025; average staff fell from 33 in 2023 to 18 in 2025.

Norway · June 2019

Revenue fell from NOK 29.8M in 2024 to NOK 13.6M in 2025; wage costs halved from 2023 to 2025

Italy · October 2021

Revenue €321.5K in 2024 with a €3.5M loss; spinal products at CE readiness only

France · June 2022

Full sea demonstration postponed to late 2026 or early 2027; no commercial installation in sources reviewed 4 Nov 2026

Estonia · June 2019

Estonian staff fell from 114 in Q2 2020 to 1 in Q1 2026, per Tax and Customs Board data.

United Kingdom · October 2021

EIC grant rejected per EIC note; directors cite no yes from 200+ investors; administration 2024, liquidation 2026

Denmark · June 2019

Average staff fell from 9 in 2021 to 5 in 2025, with no funding round found and flat gross profit

Sweden · January 2020

Net loss widened to SEK 12.7M in 2022 on SEK 0.5M of sales; bankrupt in May 2024.

Netherlands · June 2021

Bankrupt 3 Mar 2026; trustee says part two of a ~EUR 13M commitment was not awarded; causes under investigation.

Israel · October 2021

No clinical study by the Aug 2025 project end (CORDIS); EIC Fund round Sep 2022; no later round located.

Sweden · April 2019

Turnover fell to SEK 7.8M in 2025 with a SEK 3.8M loss, seven staff and negative equity

Netherlands · October 2019

Bankrupt in June 2023 with 28 staff, down from 60 the year before, per the curator

Israel · June 2019

Started a voluntary dissolution in July 2023; the register now shows it in court liquidation

France · January 2019

French unit lost €8.5M in the year to May 2025; the founders wound Hokodo up in late 2025

Denmark · March 2020

Sales activities cut back in 2025, development projects written off and staff flat at 19

Belgium · October 2020

Staff costs fell from €535,567 in 2022 to €233,858 in 2024; cash fell to €21,355 by end 2024

Belgium · April 2019

About 100 Oevel jobs cut after a December 2024 notice, and about 100 more announced in early 2026

Denmark · November 2023

Laid off all 32 employees and suspended operations in June 2026 after a DKK 135.5M loss.

Finland · January 2020

Staff fell from 13 to 5 between 2022 and 2024; bankrupt since 27 November 2025

United Kingdom · March 2022

Entered administration July 2024, described as pre-revenue; in creditors' voluntary liquidation since July 2025

France · May 2020

Net loss rose to €4.52M in 2025 with no Series B lead found; liquidation ordered in September 2026

Spain · October 2021

Register puts sales at €500,000 to €1M a year; last reported round a 2023 bridge round of undisclosed size

Belgium · October 2021

Three utility pilots (CORDIS); 2025 accounts: EUR 1.31M loss, EUR 356K negative equity; capital filing July 2026.

Sweden · March 2020

Staff fell from 18 in 2022 to 6 in the 2024 and 2025 accounts; no new round announced since 2024

United Kingdom · October 2019

Staff fell from 29 in 2021 to 23 in 2025 as net liabilities rose to £8.9M, funded by parent loans

Netherlands · March 2020

Dissolved in 2025: the operating company left the Dutch register in October, the holding in December

Israel · January 2020

Ceased operating in February 2025 per Startupim; in voluntary liquidation; no round found after the 2022 Series A

Finland · April 2019

Staff fell from 70 to 46 between the 2023 and 2025 accounts; no company-announced round since March 2024.

France · April 2019

Net loss rose from €33,795 in 2021 to €1,072,042 in 2024; safeguard proceedings opened in June 2025.

Poland · June 2019

In court restructuring since 2024; temporary court supervisor named in April 2026; no accounts after 2023

Sweden · March 2020

Staff fell from 12 in 2022 to 8 in 2025, and equity turned negative at SEK -4.3M in 2025

Norway · March 2022

No CE Mark or launch shown in sources reviewed on 4 Nov 2026; six employees and NOK 1.4M operating income in 2025

Norway · October 2022

2025 revenue NOK 9.6M against a NOK 26.2M net loss; equity negative at NOK 47.7M.

Germany · June 2021

Insolvency proceedings opened in August 2025, about 32 months after a €13M financing announcement

Spain · April 2019

Press reported 30 staff in 2021, Empresia lists 11; insolvency and liquidation opened in March 2025.

Israel · March 2020

No funding round after the 2022 seed, no news since September 2024, website parked by December 2025

Sweden · June 2021

Two employees and SEK 1.9M revenue in 2025 accounts; InnoMatch demo-vehicle pilot with FAIV AB, no result located

Hungary · October 2020

Average staff fell from 15 in 2023 to 7 in 2025, with yearly losses of HUF 134M to 172M

Ireland · March 2020

Failed to raise further funds; liquidator appointed in January 2023 and company dissolved in January 2025

Denmark · January 2023

Average staff fell from 49 to 37 in 2025; gross loss of DKK 20M and negative equity at year end.

Germany · October 2020

Insolvency proceedings in self-administration opened in June 2025, 13 months after the EIC project ended.

Estonia · October 2020

Staff fell from 15 in 2022 to 1 in 2024; revenue was zero in 2024 and 2025

Finland · June 2019

Bankrupt in March 2022 with €15,000 revenue and 7 staff in its last accounts; ceased October 2023

Spain · January 2020

Staff was about 20 in September 2025, against 18 in 2021 and a forecast of about 40 for 2025.

Denmark · March 2020

Average staff fell from 13 in 2021 to 4 in 2025; equity was DKK -19.4M at the end of 2025

United Kingdom · June 2019

Parent staff fell from 16 in 2024 to 5 in 2025, and the group entered administration in June 2026

France · May 2020

Receivership opened in April 2026 and converted to liquidation in June 2026 after a €1.21M loss in 2024

France · October 2021

Liquidated in 2023; liquidation closed for insufficient assets and company struck off in 2025

Italy · October 2019

2021 accounts: €64,597 revenue and a €317,144 loss; judicial liquidation opened in April 2024.

Germany · April 2019

Filed for insolvency in October 2022 after revenue fell from 2020; proceedings opened January 2023.

Belgium · March 2020

Average staff fell from 19.1 FTE in 2021 to 14.4 FTE in 2025, per filed annual accounts.

Netherlands · October 2022

Declared bankrupt on 28 May 2026 after failing to raise €20M; no aircraft flown in sources reviewed.

Sweden · January 2019

Staff fell from 13 in 2021 to 7 in 2025 while the company posted a loss in each of those five years

Hungary · January 2019

Revenue fell from HUF 39.5M in 2024 to HUF 798,000 in 2025; the 2025 accounts show no staff

Israel · March 2024

Revenue fell 16% to $17.0M in 2025 with a net loss of $23.9M, and the EIC equity investment did not materialise.

France · June 2022

Judicial liquidation opened on 17 April 2025 after payments stopped on 28 March 2025

Italy · April 2019

Revenue fell from €1.23M in 2020 to €390,899 in 2025 in the filed accounts; 6 to 9 staff listed.

France · June 2022

Revenue of €166,000 in 2023; court safeguard opened February 2026, nine-year plan adopted September 2026

Estonia · March 2024

Revenue was €20,470 in 2025, after two years of EIC funding and a platform covering 20 countries.

Spain · January 2019

Said in 2026 it had ceased operations; Empresia lists annual sales under €500,000 and 7 staff.

Sweden · April 2019

Reorganised to 36 staff, Wales office closed in 2025; no net sales and a SEK 15.4M operating loss in H1 2026

Norway · October 2019

Wage costs fell from NOK 13.7M in 2023 to NOK 4.9M in 2025 as sales fell for two years running

Belgium · October 2019

Net losses of €1.00M, €0.97M and €0.94M in 2023 to 2025; cash fell 87% to €232,179 in 2025

Spain · March 2020

Staff fell 20% to 12 in 2024 per Informa, and no product had reached the market by October 2026

United Kingdom · January 2023

Placed in creditors' voluntary liquidation in December 2025 with an estimated £755,145 shortfall to creditors.

Belgium · March 2020

Average staff fell from 18.4 to 12.2 FTE between 2023 and 2025; cash was €273k at end 2025

United Kingdom · October 2022

Cash of £1,373 and net liabilities of £216,728 at August 2025; average staff fell from 17 to 14.

Spain · October 2021

Revenue of just over €3M in 2025 against a CORDIS forecast of €40M by 2028

Slovenia · May 2020

Revenue was €10,978 in 2025 against a €229,050 loss; staff fell from 5 in 2023 to 3 in 2025.

Norway · June 2019

Group sales fell from NOK 113.6M in 2023 to NOK 79.5M in 2025 as the net loss doubled

Norway · May 2020

Declared bankrupt in March 2025; the last filed accounts (2023) show a NOK 48.8M loss and negative equity

Belgium · October 2024

Equity fell from €1.02M in 2020 to minus €1.69M at the end of 2024, before the sale to Soda

Switzerland · June 2019

Project website offline by August 2026; no product launch or funding round announced since the 2019 award

Iceland · May 2020

VAT registration cancelled in July 2022; no funding round, partner or product announced since 2021

Estonia · June 2022

No CE Mark by June 2026; the large trial had enrolled over 120 patients and is registered to complete in December 2026

Israel · March 2020

Staff fell from 35 in 2021 to 20 in 2023; an insolvency order was registered in April 2026.

United Kingdom · October 2020

Entered administration in February 2024 with 32 staff, down from a peak of 81; dissolved in May 2026.

Israel · June 2019

Qualigen ended its $10.4M funding pledge in 2023; the 2025 bridge round sought only $500,000

Israel · October 2019

In court liquidation per the 2026 register; operations ceased in November 2025 per Startupim

Poland · January 2019

Remedial proceedings opened in 2025; 2024 revenue was PLN 356.7k against a PLN 2.6M loss

Germany · June 2019

Insolvency was entered in the Berlin register in November 2019, five months after the EIC selection.

United Kingdom · March 2022

Entered administration on 1 February 2023 and was dissolved on 2 May 2024; its IP sold for £1,000

France · January 2019

Court safeguard procedure opened in June 2022; losses every year since and 3 to 5 staff in 2024

Spain · March 2022

No CE Mark or product launch by September 2026, against market entry planned for late 2023

Finland · March 2020

Staff fell from 39 to 15 and revenue from €1.10M to €0.22M between the 2021 and 2025 accounts

Poland · March 2022

Nevomo Poland's reported accounts show PLN 473k operating revenue in 2024; its projects are pilots and memoranda

France · January 2020

Staff fell from 24 at the 2022 project end to 17 in 2025; revenue was €1.09M in 2025

Switzerland · April 2019

Bankruptcy opened in December 2023; proceedings suspended for lack of assets in January 2025.

United Kingdom · October 2021

Staff fell from 39 in 2023 to 28 in 2025; £11.8M impairment of tidal technology in 2024

Spain · October 2021

Register puts annual sales under €500,000 with 22 employees, despite distributors in seven countries

Ireland · May 2020

Liquidator appointed in November 2024; the company was dissolved on 8 August 2026.

Denmark · October 2019

Declared bankrupt in March 2024; its robots and machines were sold at auction in July 2024.

Germany · March 2020

Insolvency proceedings opened in December 2024 after sales missed targets; the business was sold to Emoving GmbH

France · October 2021

No O2L-001 trial located in ClinicalTrials.gov search; judicial liquidation and asset sale plan in 2026

Israel · January 2019

Sources reviewed in Nov 2026 show no announced product launch, certification or customer.

Spain · October 2019

Insolvency case 515/2023 opened; a court closed it in July 2024 for lack of assets

United Kingdom · January 2019

Entered administration in February 2026; all but 8 of 163 UK staff were made redundant.

Poland · October 2021

Demo line; EIC Fund loan closed Oct 2024; substrate in trials in 2026; no customers named in sources reviewed

Israel · June 2019

Entered court insolvency proceedings in March 2024 and was listed as ceasing to operate in August 2024

Finland · June 2019

Staff fell from 12 to 0 and revenue from €656k to €64k between the 2021 and 2025 accounts

United Kingdom · October 2021

Headcount flat at 22-23 in 2023-24; cash fell from £4.17M to £1.6M; no round announced since 2022 (checked 4 Nov 2026)

Ireland · January 2019

17 staff in October 2024 against a 2023 plan for 75 by 2026; the hiring target has moved to 2029

Iceland · June 2019

Iceland's second-tier league cut OZ from 13 venues in 2023 to 3 in 2025 and ended its media hub contract.

Spain · October 2021

No partner or Phase 3 announced for PBF-680 two years after positive Phase 2 results

Finland · June 2022

Revenue fell from €10.8M in 2022 to €3.9M in 2025 while the operating loss grew to €5.3M

Denmark · October 2025

Gross profit fell from DKK 35.1M in 2023 to DKK 1.0M in 2025, with a DKK 37.5M loss in 2025

Portugal · March 2022

Sales in Iberinform's band of up to €2M, against over €40M revenue promised for 2026

Finland · March 2022

Revenue fell from €105,000 in 2023 to €19,000 in 2025 and staff from 19 to 10

Hungary · January 2019

Staff of 18 in 2022 and 17 in 2024; a HUF 69.3M net loss in the 2024 accounts

Belgium · March 2024

Bankrupt in April 2025, CEO cited too few orders; the EIC project was terminated in July 2025.

Netherlands · June 2019

Declared bankrupt in February 2025; patents, strains and plant sold for €300,000 in June 2025.

Norway · October 2019

2025 revenue NOK 451,628 against a net loss of NOK 31.8 million; equity NOK 2.1 million.

Ireland · June 2019

Creditors' liquidation opened in February 2026; the liquidators put its software IP up for sale in 2026.

France · March 2020

Receivership in February 2023 and liquidation in April 2023, with 27 staff when proceedings opened

Germany · October 2021

Provisional insolvency (Mar 2026), proceedings opened, listed in liquidation; Fugro says it integrated the technology.

Slovenia · May 2020

Staff fell from 7.46 to 3.91 and revenue from €604k to €396k between the 2023 and 2025 accounts.

Italy · May 2020

Revenue fell from €7.53M in 2019 to €5.44M in 2024 in the filed accounts.

Germany · June 2021

Court notice records provisional administration (Jan 2026) and proceedings opened (Mar 2026); cause not established

Netherlands · October 2022

Declared bankrupt in May 2024; bankruptcy wound up in February 2026; no clinical trial reported.

Finland · March 2020

Revenue fell from €476,000 in 2022 to €72,000 in 2025 while staff stayed at 9 to 10

France · June 2022

Revenue fell from €4.31M in 2022 to €3.04M in 2024; receivership in May 2026

France · November 2023

Stopped paying debts in February 2026 and was placed in judicial liquidation in April 2026.

Sweden · November 2023

Net sales fell 34% to SEK 6.7M in 2025/26 and staff fell from 20 to 15.

Belgium · June 2023

Staff fell from 14.2 to 6.2 FTEs between 2023 and 2025, and equity dropped to €471,489.

Germany · October 2019

The grant-holder entered liquidation in November 2021; its business moved to a new company

Denmark · March 2020

Owner decided in 2026 to close it after a DKK 8.0M loss in 2025 cut equity to DKK 3.2M

Estonia · June 2023

Sales revenue was €27,272 in 2025, against €1.19 million of other operating income.

Netherlands · April 2019

Revenue of €2.23M in 2023 and €2.56M in 2025; output steady at 8 generator systems a year in 2024 and 2025

Netherlands · May 2020

SEC filings list 32 employees at end-2023 and 19 employees and contractors at end-2024 (not like for like)

Denmark · May 2020

All three recycling plants failed between December 2024 and April 2025; no staff budgeted for 2025

Germany · June 2022

Insolvent in February 2025, five months after a €5M round; listed in liquidation from May 2025 per North Data

Denmark · March 2023

Pivotal trial stopped for lack of effect; company dissolved after voluntary liquidation in May 2026.

Sweden · June 2022

Net sales of SEK 1.3M in 2024 with a SEK 5.0M loss and SEK 0.26M in cash at year end

Poland · June 2019

Last product news in March 2022, website parked since 2024, 2023 accounts filed only in May 2026

Sweden · June 2022

No plant reported built; turnover fell to SEK 7.7M in 2025 with six staff and a SEK 2.2M loss

Israel · October 2020

Website offline since August 2024; last annual report on file is for 2023 and the register flags it as violating

France · June 2023

No revenue, 3 to 5 employees, and its drug had not entered human testing by the end of the EIC project.

Israel · March 2022

No CE Mark or FDA approval by September 2026, against a 2024 launch and €15M revenue promised for 2025

Denmark · June 2019

Staff fell from 2 in 2021 to 0 from 2023; the Danish unit reported no activity in 2025

Italy · March 2022

Revenue fell from €762k in 2024 to €353k in 2025, with a €892k net loss

Austria · March 2020

Bankrupt in July 2022 with €1.4M of liabilities; the Austrian GmbH was deleted from the register in July 2024.

Netherlands · April 2019

Balance sheet fell from €1.13M at end 2020 to €8,430 at end 2023, with no staff; the BV closed in 2025

France · March 2022

Payments stopped on 24 March 2026; receivership from 2 April and judicial liquidation from 15 June 2026

Denmark · January 2020

Staff fell from 14 in 2023 to 11 in 2025; development paused and staff dismissed in January 2026

Denmark · January 2023

2025 gross loss of DKK 0.7M, net loss DKK 55.5M, equity minus DKK 114M; staff fell from 31 to 27.

France · June 2023

Revenue was €41,958 in 2023; 2024 revenue is not disclosed in the public ratios dataset.

Sweden · October 2021

No product sales; first human implant readiness now targeted for February 2028

Austria · April 2019

Staff fell from about 50 in September 2023 to 10 at the June 2026 insolvency filing.

Switzerland · January 2020

Investor PVA TePla wrote its 23.9% stake down to zero at the end of 2025, citing operational challenges.

France · March 2022

Judicial liquidation opened on 18 September 2024 after payments stopped on 6 September

United Kingdom · October 2020

Average staff fell from 11 to 3 between the 2023 and 2025 accounts; cash dropped to £8,601.

Denmark · March 2022

Staff fell from 93 in 2023 to 54 in 2025 while the annual loss rose to DKK 43.4M

France · January 2019

Receivership opened in July 2025 and converted to liquidation in November 2025 after no buyer came forward.

Switzerland · March 2020

Staff fell from over 30 in October 2021 to 19 at the June 2023 sale to Q-SYS.

France · October 2020

Liquidation opened in May 2025; the net loss grew from €0.53M in 2022 to €1.18M in 2023.

Estonia · March 2022

Sales revenue of €93,430 in 2025 and four employees in the second quarter of 2026

Latvia · March 2020

Staff fell from 42 in 2022 to 28 in 2025 and turnover stayed below €0.9M a year in 2019 to 2025

France · January 2020

Liquidated in October 2023; the case closed in May 2024 for insufficient assets, after no Series A was announced.

Netherlands · June 2019

Staff fell from 51 in the 2022 accounts to 40 in 2024 and 2025; equity fell 19% in 2025.

Spain · October 2021

Pilot line of 100 pairs a day; annual sales below €500,000 per register data

Spain · April 2019

Register puts turnover under €500K; in 2024 the business was sold to Numintec as a unit

France · January 2023

Entered receivership in March 2025 and liquidation in June 2025; assets sold for €250,000.

Germany · October 2019

Filed for insolvency in December 2023 with 25 staff, seven months after a €3.6M bridge round

Germany · June 2019

No funding round since the 2021 seed and no launch of the gloves promised for 2025 found by October 2026

Belgium · October 2019

Equity fell from €817,706 in 2021 to minus €1,650,668 in 2024; bankrupt in June 2026

Ukraine · January 2019

US parent's revenue fell from $49,878 in 2020 to $19,853 in 2022, with a $524,015 loss in 2022

United Kingdom · June 2023

Staff fell from 12 to 9 between 2023 and 2026, and cash dropped to £113,155 in June 2026.

Spain · March 2020

Declared insolvent without assets in July 2024; its website was disabled by August 2024

Israel · April 2019

Equity fell from NIS 19.9M in June 2024 to NIS 2.2M in June 2026; 6 staff listed in 2026

Finland · March 2020

Revenue fell from €1.57M in 2022 to €1.08M in 2025 while the operating loss grew to €2.26M

Israel · June 2019

Last annual report filed for 2023; flagged a violating company and its website offline by 2026.

France · October 2021

Turnover not disclosed in 2024 accounts; company reported trial preparations; judicial reorganization opened Aug 2026

Denmark · June 2019

Equity fell to DKK -8.44M in the 2021 accounts; bankruptcy followed in November 2022.

Denmark · June 2021

Staff fell to 6 and equity to DKK 2.98M in the 2025 accounts

Spain · October 2021

No CE mark or launch found in sources reviewed 4 Nov 2026; register data put sales under €500,000 a year

Denmark · October 2021

Declared bankrupt on 21 May 2024 before the project ended; CORDIS marks it closed with no public results report.

Sweden · June 2022

Turnover fell from SEK 14.9M in 2024 to SEK 2.6M in 2025 with a SEK 20.5M loss and 14 staff

Germany · March 2020

Insolvency opened in January 2024; the company was struck off the register as assetless in March 2025

Hungary · January 2019

Net revenue of HUF 3.291M (€9,013) in its last filed accounts, for 2020; zero staff in 2025.

Romania · May 2020

Staff fell from 7 to 2 in the 2023 accounts; insolvency opened in February 2025

Belgium · June 2022

Staff fell from 21.7 to 11.7 FTE in 2023-2025; 2025 loss €8.0M with equity down to €3.0M

France · June 2021

Receivership on 9 July 2025 and liquidation from 22 July 2025

Sweden · October 2021

Ceased operations in July 2023 after failing to raise capital, per CORDIS; no preclinical or clinical trials started

Italy · April 2019

Revenue fell from €2.25M in 2022 to €410,840 in 2024; 4 employees listed, against 18 in 2019

Israel · June 2019

2026 IPO filing shows three full-time staff, $2.0M cash at end-2025 and going-concern doubt

Italy · May 2020

Successor Tecno Italia Digital's revenue fell from €4.02M in 2022 to €2.93M in 2023, with a loss

Belgium · October 2019

Lost €3.28M in 2023, handed its activities to Wavenet in June 2024 and was dissolved in February 2026

Denmark · January 2019

Gross profit DKK 14.02M in 2024/25 against 14.68M in 2018/19, with a DKK 2.65M net loss in 2024/25

Denmark · March 2020

Average staff fell from 7 in 2020/21 to 0 in 2023/24 and 2024/25; product assets written to zero in 2022/23

Belgium · January 2019

Staff averaged 9.6 FTE in 2023 against 125 planned; Bosch dissolved the company in December 2024.

Germany · March 2022

Provisional insolvency administrator appointed by the Mannheim court on 26 March 2024

Germany · January 2020

Filed for insolvency in November 2022 with 24 staff; successor Meysens got an insolvency court order in November 2024.

United Kingdom · April 2019

Staff fell from 8 to 3 between the 2022 and 2024 accounts; liquidation began in January 2025

Bulgaria · October 2019

Register data via finansi.bg show revenue down 10.6% in 2025 and 31 staff now, against 39 average insured in 2023

Germany · June 2022

In insolvency proceedings in 2026; administrator agreed a €5,000 sale of IP rights under a 12 May 2026 contract

Belgium · April 2019

Average staff fell from 6.9 FTE in 2020 to 4.9 in 2025; losses of €1.72M in 2024 and €1.94M in 2025

Netherlands · May 2020

Declared bankrupt on 13 December 2024, nine months after its EIC project ended

Germany · March 2023

Beneficiary entered liquidation in October 2025 with €68,227 equity at end of 2024.

France · October 2021

The company said it could no longer sustain the app; judicial liquidation opened October 2025

France · June 2021

Receivership in October 2024 and liquidation from July 2025

Poland · May 2020

Deleted its Spanish and Gutkowo branches from the register in October 2024

Sweden · June 2019

Bankrupt in January 2021 with about 20 staff after Region Skåne and Västra Götaland ended its contract

Israel · October 2021

OVAL did not meet its primary endpoints; successor Notable Labs filed voluntary Chapter 7 petitions in October 2024

Switzerland · May 2020

Bankrupt in May 2025 with at most CHF 12,000 of assets, per the bankruptcy office.

Netherlands · March 2020

Revenue fell from €2.95M in 2020 to €0.74M in 2022; bankrupt in June 2023 with 12 staff left

Belgium · October 2022

Turnover of €22,546 in 2025 with a €2.02M loss; the test had not been CE-marked

Germany · March 2022

Insolvency application 29 Dec 2025; provisional administrator 30 Jan 2026; proceedings opened 1 May 2026

Denmark · March 2020

Average staff fell from 13 in 2021 to 7 in 2025; 2025 revenue was DKK 5.3M against DKK 10.2M in 2022

Denmark · March 2020

Average full-time staff fell from 8 in 2021 to 2 in 2025; gross profit turned negative in 2024 and 2025.

Denmark · October 2020

Average staff was 10 in both the 2019/20 and 2025/26 accounts; net profit fell to DKK 1.47M in 2025/26

Italy · June 2021

Secondary account summaries report 2025 revenue of €73,600 and net loss of €901,900

France · May 2020

Receivership opened in October 2025; liquidation and asset sale to Aura Aero in June 2026.

Denmark · June 2019

UK parent staff fell from 11 to 7 in 2025 and its shareholders' funds reached minus £382,691

Norway · May 2020

Filed for its own bankruptcy in June 2023; unsecured creditors received a 1.2341% dividend in 2024

Israel · June 2021

Shut down in August 2026 after failing to raise enough to expand

Finland · October 2019

Declared bankrupt in December 2025 after a failed restructuring; 2024 net loss of about €2.3M

Finland · October 2020

Revenue fell 30.3% to €606,000 in 2024 with 27 staff; declared bankrupt in May 2026.

Sweden · March 2022

Net sales of SEK 1.7M in 2024, down from SEK 3.0M in 2023, with a SEK 12.1M net loss

Netherlands · October 2022

Ceased operations in March 2023 after its Phase 3 trial was stopped; Kompass lists it in liquidation.

Belgium · March 2022

Gross margin fell from €4.41M to €2.93M and net loss grew to €2.15M in the year to June 2025

France · October 2019

Net loss rose to €2.59M on €264,748 of sales in 2024; court restructuring opened in 2026

Spain · January 2019

Staff fell from over 25 in 2018 to 1 to 9 per Infoempresa; all directors resigned between 2024 and 2026

Sweden · June 2023

Net sales were SEK 117,000 in 2025, its first, against SEK 13.2 million of other income.

Italy · April 2019

France · October 2022

Netherlands · January 2019

Spain · October 2022

United Kingdom · June 2022

Germany · October 2021

Germany · March 2022

Germany · June 2019

France · June 2021

Italy · October 2021

Spain · January 2019

Croatia · October 2021

Denmark · March 2025

Switzerland · October 2020

Portugal · March 2022

Italy · October 2024

Ireland · June 2021

United Kingdom · October 2022

Spain · November 2023

France · March 2022

Ireland · April 2019

Denmark · January 2019

Ireland · March 2024

Sweden · October 2025

Italy · October 2022

Sweden · October 2024

Spain · October 2019

Turkey · October 2019

Belgium · March 2025

Netherlands · March 2022

Germany · March 2023

France · June 2022

Poland · March 2025

France · October 2021

Finland · March 2022

France · March 2024

Netherlands · June 2019

Spain · November 2023

Ireland · June 2022

Netherlands · October 2021

Ireland · March 2020

Spain · January 2019

Portugal · June 2021

United Kingdom · March 2022

Iceland · October 2022

Greece · March 2024

Israel · October 2019

Luxembourg · October 2022

Spain · June 2022

Finland · October 2021

Germany · October 2025

Netherlands · October 2024

France · March 2024

Ireland · June 2019

Netherlands · March 2022

Ireland · June 2022

Netherlands · June 2022

Finland · October 2022

France · June 2023

France · June 2023

France · October 2022

Ireland · June 2021

France · June 2022

Netherlands · March 2020

Belgium · October 2022

France · January 2020

Portugal · January 2023

Ireland · April 2019

Poland · January 2023

Spain · May 2020

Portugal · March 2024

United Kingdom · January 2020

Denmark · January 2023

Belgium · March 2024

Spain · April 2019

Ireland · March 2023

Germany · October 2024

Spain · October 2025

Germany · June 2022

Sweden · March 2024

Switzerland · April 2019

Netherlands · June 2021

Strategic investments and public production-facility support reported; these do not establish commercial scale.

Austria · October 2022

Ireland · April 2019

Norway · June 2021

Belgium · January 2019

Denmark · October 2021

France · March 2022

Israel · October 2019

Finland · October 2021

Spain · March 2024

Spain · March 2025

Sweden · June 2022

France · June 2022

Spain · January 2019

France · October 2025

Poland · March 2022

Israel · May 2026

Ireland · October 2019

Poland · October 2024

Cyprus · June 2023

Netherlands · October 2024

Denmark · April 2019

United Kingdom · March 2022

Germany · March 2023

Finland · March 2025

Sweden · October 2025

France · March 2023

Germany · March 2024

Austria · October 2021

Portugal · June 2019

Sweden · October 2022

Bulgaria · January 2023

France · March 2024

France · March 2024

Portugal · April 2019

Germany · October 2021

France · June 2021

Announced over €7M funding in June 2024; production volumes unverified and 2025 accounts report a loss

Israel · October 2021

EoCene says the US pivotal trial is active; one German hospital used the device in 2024. Sales not established.

Israel · October 2021

Sweden · November 2023

Germany · March 2022

Spain · October 2024

Ireland · June 2021

Austria · March 2020

Belgium · March 2023

Denmark · March 2025

Germany · October 2025

France · March 2022

Israel · June 2021

KPro remains investigational; trial mirrors report termination. Other products do not show current commercial growth

Germany · October 2022

France · January 2020

Italy · June 2019

Netherlands · January 2023

Spain · October 2025

Ireland · June 2021

Further funding and clinical development documented; neither establishes commercial sales or production scale

Israel · October 2019

Germany · March 2022

United Kingdom · June 2022

Austria · April 2019

France · March 2020

Germany · October 2020

Denmark · May 2020

Sweden · October 2022

Germany · October 2025

United Kingdom · October 2022

Israel · October 2024

Netherlands · October 2024

Netherlands · June 2021

Portugal · November 2023

Netherlands · October 2021

Italy · January 2019

Germany · March 2022

Italy · March 2024

Netherlands · October 2022

Austria · June 2023

France · March 2023

Norway · November 2023

Iceland · March 2022

Germany · March 2024

United Kingdom · October 2022

Belgium · June 2022

Austria · October 2024

Germany · March 2025

Hungary · October 2025

Israel · April 2019

Switzerland · October 2019

Sweden · October 2022

Spain · October 2022

Israel · June 2022

Sweden · March 2022

Sweden · January 2023

Sweden · October 2022

Germany · June 2019

Israel · June 2022

Denmark · October 2022

France · October 2021

Germany · October 2021

Austria · October 2025

Germany · March 2022

Ireland · October 2021

$60M round (Jan 2026); Bell-1/RacQ installed at ESA (Jul 2026); these facts alone do not establish commercial scale

France · June 2023

Israel · March 2023

Spain · October 2024

France · June 2023

France · June 2021

EUR 10M financing announced in 2025 and manufacturing plans; commercial output and revenue unquantified.

United Kingdom · October 2025

Norway · March 2023

Germany · March 2025

Italy · March 2024

Israel · March 2020

France · June 2022

Sweden · October 2022

Israel · March 2022

Germany · April 2019

Germany · October 2022

Spain · November 2023

Finland · October 2024

Israel · June 2019

France · June 2022

Netherlands · November 2023

Spain · October 2022

Spain · October 2025

Italy · October 2025

Germany · October 2024

Denmark · January 2020

Spain · June 2021

Netherlands · March 2024

Israel · October 2021

Germany · March 2022

France · June 2021

€36M financing announced in 2022-23; R&D and support headcount grew; commercial scale is unverified

Italy · April 2019

Spain · October 2022

Netherlands · October 2021

Netherlands · June 2022

Sweden · November 2023

Estonia · March 2023

Croatia · March 2024

Israel · March 2022

Germany · October 2021

Ireland · October 2019

Finland · March 2025

France · March 2023

Switzerland · April 2019

Finland · June 2021

Staff grew to 52 in 2025 accounts; commercial product sales remain unverified.

Norway · June 2022

Slovakia · June 2021

Israel · March 2020

Denmark · June 2022

France · October 2025

United Kingdom · October 2022

France · October 2025

Israel · October 2021

France · October 2021

Germany · June 2021

Germany · June 2023

Germany · October 2021

Norway · June 2022

France · June 2023

Finland · October 2022

Germany · October 2025

Germany · June 2022

Denmark · June 2021

€23M Series A in December 2023

Austria · October 2024

Ireland · March 2023

Italy · March 2023

Netherlands · March 2022

Germany · January 2023

Portugal · March 2023

Switzerland · October 2019

Finland · October 2025

France · May 2026

Germany · October 2022

Spain · April 2019

Portugal · January 2023

Portugal · June 2022

Israel · March 2024

Netherlands · June 2022

Spain · October 2022

France · October 2022

Spain · January 2019

Spain · March 2024

Germany · June 2019

Spain · January 2019

Netherlands · June 2019

Israel · June 2021

Financing and feasibility enrollment show progress; sources reviewed do not establish commercial sales growth

Sweden · January 2023

Netherlands · October 2022

Denmark · June 2021

$11.7M Series A in December 2024 led by Serum Institute of India

Netherlands · October 2025

France · March 2024

Spain · March 2024

Sweden · June 2021

Austria · October 2022

Switzerland · June 2019

Germany · October 2020

Ireland · March 2022

Germany · October 2024

Netherlands · October 2022

Germany · October 2022

Slovenia · June 2022

Germany · October 2019

Israel · March 2024

Germany · January 2020

Denmark · June 2021

Record net loss of DKK 21.8M in 2025 and equity down two thirds in two years

Austria · October 2022

Switzerland · April 2019

France · April 2019

Norway · June 2019

France · March 2022

Luxembourg · May 2026

Germany · January 2019

Denmark · March 2022

France · March 2024

Bulgaria · October 2021

Germany · March 2024

France · March 2024

Germany · October 2025

Germany · May 2026

United Kingdom · June 2022

Israel · April 2019

Lithuania · October 2021

Germany · June 2019

Israel · March 2024

Finland · March 2023

France · October 2021

Austria · June 2019

Ireland · March 2022

Germany · March 2023

United Kingdom · March 2023

Israel · October 2024

Hungary · June 2023

United Kingdom · October 2021

Germany · October 2021

CORDIS reports a demonstrator; sources reviewed show no customer deployment. Insolvency proceedings opened April 2026.

Netherlands · March 2023

Israel · October 2024

Germany · October 2021

Netherlands · May 2026

France · June 2022

Switzerland · June 2019

France · October 2025

Spain · January 2023

Spain · June 2022

Germany · October 2024

Israel · June 2019

Netherlands · April 2019

Spain · January 2019

Spain · June 2019

Spain · March 2023

Sweden · October 2021

Finland · June 2021

Czechia · October 2021

Spain · October 2024

Norway · October 2020

Italy · November 2023

Sweden · March 2023

Sweden · March 2024

Estonia · June 2021

United Kingdom · March 2022

Germany · March 2022

Israel · October 2019

Germany · October 2024

Italy · June 2023

Germany · October 2022